Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glutamic Acid to Decrease Vincristine Toxicity in Children With Cancer

NCT00369564 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT00369564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00369564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glutamic Acid to Decrease Vincristine Toxicity in Children With Cancer
Lead sponsor
University of South Florida
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2007
Completion date
November 30, 2012
Enrollment
250 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, leukemia, lymphoma, neurotoxicity, peripheral neuropathy, sarcoma